29 January 2024
As lead sponsor of the event, Illumina conducted two keynote sessions. Patrick Tarpey, PhD, lead clinical scientist for Solid Cancer at the East Genomic Laboratory Hub at Cambridge University Hospitals NHS, led a panel discussion on the first day, exploring the “Expansive Analysis of NGS Data in Solid Cancer” and unveiling innovative approaches in genomic data analysis. The next day featured Ana-Maria Cujba, PhD, from the Wellcome Sanger Institute, who presented “Harnessing Single-Cell and Spatial Technologies for Human Cell Atlasing in Health and Disease.”
At the Illumina booth, the spotlight was on the new P4 flow cell powered by XLEAP-SBS chemistry for the NextSeq 2000 System. The Illumina team also demonstrated the tertiary analysis capabilities of the company’s Emedgene software, which can offer insights into hereditary disease variant interpretation.